Product Number |
ARP42237_T100 |
Product Page |
www.avivasysbio.com/idh3a-antibody-n-terminal-region-arp42237-t100.html |
Name |
IDH3A Antibody - N-terminal region (ARP42237_T100) |
Protein Size (# AA) |
366 amino acids |
Molecular Weight |
40kDa |
Subunit |
alpha, mitochondrial |
NCBI Gene Id |
3419 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
1.0 mg/ml |
Gene Full Name |
Isocitrate dehydrogenase 3 (NAD+) alpha |
Description |
|
Alias Symbols |
RP90 |
Peptide Sequence |
Synthetic peptide located within the following region: MKIFDAAKAPIQWEERNVTAIQGPGGKWMIPSEAKESMDKNKMGLKGPLK |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reference |
Soundar,S., (2003) J. Biol. Chem. 278 (52), 52146-52153 |
Description of Target |
Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. IDH3A is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase.Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. |
Protein Interactions |
HUWE1; SUMO2; STAU1; UBC; MDM2; ADRB2; gag-pol; RAB4A; MBNL1; S100A16; SUCLA2; UQCRFS1P1; SUMO4; EBNA-LP; MYC; TERF2; TERF1; PSMD4; DDA1; DMWD; IDH3B; IDH3G; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-IDH3A (ARP42237_T100) antibody |
Blocking Peptide |
For anti-IDH3A (ARP42237_T100) antibody is Catalog # AAP42237 (Previous Catalog # AAPP24660) |
Immunogen |
The immunogen is a synthetic peptide directed towards the N terminal region of human IDH3A |
Uniprot ID |
P50213 |
Protein Name |
Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial |
Publications |
Alteration of isocitrate dehydrogenase following acute ischemic injury as a means to improve cellular energetic status in neuroadaptation. CNS Neurol Disord Drug Targets. 12, 849-60 (2013). 23469839
Lin, C.-C. et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci. Rep. 2, 785 (2012). 23139858 |
Sample Type Confirmation |
IDH3A is strongly supported by BioGPS gene expression data to be expressed in Jurkat |
Protein Accession # |
NP_005521 |
Purification |
Protein A purified |
Nucleotide Accession # |
NM_005530 |
Tested Species Reactivity |
Human |
Gene Symbol |
IDH3A |
Predicted Species Reactivity |
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish |
Application |
IHC, WB, IP |
Predicted Homology Based on Immunogen Sequence |
Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 92% |
Image 1 | 293T, Liver tumor
| Host: Rabbit Target: IDH3A Positive control (+): 293T (2T) Negative control (-): Liver tumor (T-LI) Antibody concentration: 1ug/ml |
|
Image 2 | HEK293 Whole Cell Lysate
| IDH3A was immunoprecipitated from 2 mg HEK293 Whole Cell Lysate with ARP42237_T100 with 1:200 dilution. Western blot was performed using ARP42237_T100 at 1/1000 dilution. Lane 1: Control IP in HEK293 Whole Cell Lysate. Lane 2: IDH3A IP with ARP42237_T100 in HEK293 Whole Cell Lysate. Lane 3: Input of HEK293 Whole Cell Lysate. |
|
Image 3 | Human Skeletal muscle
| Rabbit Anti-IDH3A Antibody Catalog Number: ARP42237 Paraffin Embedded Tissue: Human Muscle Cellular Data: Skeletal muscle cells Antibody Concentration: 4.0-8.0 ug/ml Magnification: 400X |
|
Image 4 | Human HepG2
| Host: Rabbit Target Name: IDH3A Sample Tissue: Human HepG2 Antibody Dilution: 1.0ug/ml |
|